SPRR3 Contributes to Aggressiveness of Pancreatic Cancer Cells via NF-κB Signaling Pathway

Figure 6

Clinical correlation of SPRR3 levels and NF-κB activation in pancreatic cancer. The representative bands (left panel) and correlation analysis (right panel) of SPRR3 and p65.